货号:A197861
同义名:
Am 80;Amnolake
Tamibarotene是一种视黄酸受体 α(RARα)激动剂,ED50 为 0.79 nM,可诱导 HL-60 细胞的分化和凋亡,适用于急性白血病研究。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Retinoid acid (RA) is a metabolite of retinol that plays an important role in cell growth and differentiation. The retinoic acid receptors (RARs) and retinoid X receptors (RXRs) are two classes of nuclear receptors mediating the regulation of RA and its derivatives on gene expression. Tamibarotene is a RAR agonist selective for RARa with an Kd value of 62 nM and an AC50 value of 1.46 nM compared to RARb (Kd = 280 nM, AC50 = 6.87 nM) and RARg (Kd = 816 nM, AC50 = 148.66 nM)[3]. Incubation of HL-60 cells with tamibarotene (100 nM – 10 μM) for 9 days significantly decreased the total cell number and increased the number of dead cells at a time-dependent manner. The percentage of growth inhibition induced by 100 nM tamibarotene after 9-day incubation was 32.0, 23.7, 27.9, and 59.2% in HL60R, K562, Kasumi-1, and Meg01 cells, respectively. Tamibarotene at 10, 20, and 40 μM also induced the secretion of TGF-b2 in K562, MOLT3, Raji, and U937 cell lines with an incubation period of 3 days. Moreover, 3-day treatment of tamibarotene from 10 – 40 μM in Raji cells increased the expression ratio of phosphorylated Smad-2 relative to Smad-2 at a dose-dependent manner[4]. In C57BL/6J mice, oral administration of tamibarotene (5 mg/kg, once per day) for 4 days prevented intracerebral hemorrhage-induced neuron loss compared to vehicle-treated group. The same treatment also decreased the number of activated microglia/macrophages and the expression of HO-1 associated with intracerebral hemorrhage[5]. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
COS-1 cells | Function assay | Transcriptional activation in COS-1 cells expressing Retinoic Acid Receptor alpha (RAR alpha) | 10669568 | ||
HL60 cells | Proliferation assay | Antiproliferative activity against human HL60 cells, IC50=6 μM | 19443225 | ||
HL60 cells | Proliferation assay | 48 h | Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay, IC50=8.94 μM | 22014829 | |
Jurkat cells | Proliferation assay | Antiproliferative activity against human Jurkat cells, IC50=17.3 μM | 19443225 | ||
Dose | Mice: 2.5 mg/kg[3] (p.o.); 15 mg/kg[4] (i.p.) Rat: 2 mg/kg - 10 mg/kg[5] (p.o.) |
Administration | p.o., i.p. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02807558 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | December 2021 | United States, Iowa ... 展开 >> Recruiting Iowa City, Iowa, United States United States, Massachusetts Recruiting Boston, Massachusetts, United States United States, Michigan Recruiting Ann Arbor, Michigan, United States United States, New York Recruiting New York, New York, United States Recruiting Rochester, New York, United States United States, North Carolina Recruiting Durham, North Carolina, United States United States, Ohio Recruiting Cleveland, Ohio, United States United States, Oregon Recruiting Portland, Oregon, United States United States, Pennsylvania Recruiting Pittsburgh, Pennsylvania, United States United States, Tennessee Recruiting Nashville, Tennessee, United States United States, Texas Recruiting Houston, Texas, United States France Centre Hospitalier Universitaire Nancy Recruiting Vandoeuvre les nancy, France, 54511 Institut Gustave Roussy Recruiting Villejuif, France, 94805 收起 << |
NCT00417391 | Crohn's Disease | Phase 2 | Completed | - | Japan ... 展开 >> Toyohashi, Aichi, Japan Sakura, Chiba, Japan Sapporo, Hokkaido, Japan Nishinomiya, Hyogo, Japan Fujisawa, Kanagawa, Japan Nakagami, Okinawa, Japan Otsu, Shiga, Japan Shinjuku, Tokyo, Japan 收起 << |
NCT01226147 | Lupus Nephritis | Phase 2 | Unknown | February 2013 | Japan ... 展开 >> Kinki University Hospital Recruiting Osaka, Japan, 5898511 Contact: Masanori Funauchi, M.D. mn-funa@med.kindai.ac.jp Principal Investigator: Masanori Funauchi, M.D. 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.85mL 0.57mL 0.28mL |
14.23mL 2.85mL 1.42mL |
28.45mL 5.69mL 2.85mL |
CAS号 | 94497-51-5 |
分子式 | C22H25NO3 |
分子量 | 351.439 |
别名 | Am 80;Amnolake;SY-1425;Retinobenzoic acid, Amnoid, AMNOLAKE, Am80, Am 80, Am-80;Retinobenzoic Acid;NSC 608000 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,Store in freezer, under -20°C |
溶解方案 |
DMSO: 25 mg/mL(71.14 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |
IP 2% DMSO+2% Tween80+40% PEG300+water 10 mg/mL clear PO 0.5% CMC-Na 56 mg/mL suspension |